Efficacy and safety of hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) on anemia in non-dialysis-dependent chronic kidney disease (NDD-CKD): a systematic review and meta-analysis
ConclusionHIF-PHI improves renal anemia and iron utilization disorder in NDD-CKD patients, without significantly more adverse events.
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research
More News: Anemia | Chronic Kidney Disease | Databases & Libraries | Dialysis | Iron | Statistics | Study | Urology & Nephrology